BA
AGN

Boston Advisors’s Allergan plc AGN Stock Holding History

Boston Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$232K Hold
1,380
– – 0.01% 560
2019
Q2 		$231K Hold
1,380
– – 0.01% 604
2019
Q1 		$202K Buy
+1,380
New +$200K 0.01% 617
2018
Q4 		– Sell
-1,595
Closed -$304K – 681
2018
Q3 		$304K Sell
1,595
-40
-2% -$7.35K 0.01% 555
2018
Q2 		$273K Sell
1,635
-85
-5% -$13.6K 0.01% 592
2018
Q1 		$289K Sell
1,720
-19,716
-92% -$3.31M 0.01% 567
2017
Q4 		$3.51M Sell
21,436
-1,018
-5% -$183K 0.08% 246
2017
Q3 		$4.6M Buy
22,454
+1,079
+5% +$251K 0.1% 222
2017
Q2 		$5.2M Buy
21,375
+16,426
+332% +$3.86M 0.12% 210
2017
Q1 		$1.18M Sell
4,949
-11
-0.2% -$2.56K 0.03% 335
2016
Q4 		$1.04M Sell
4,960
-5,265
-51% -$1.09M 0.02% 357
2016
Q3 		$2.35M Sell
10,225
-5,878
-37% -$1.44M 0.06% 273
2016
Q2 		$3.72M Buy
16,103
+455
+3% +$105K 0.09% 235
2016
Q1 		$4.19M Sell
15,648
-92,676
-86% -$26.5M 0.1% 206
2015
Q4 		$33.9M Buy
108,324
+75,380
+229% +$22.4M 0.79% 26
2015
Q3 		$8.96M Sell
32,944
-7,773
-19% -$2.39M 0.34% 87
2015
Q2 		$12.4M Buy
40,717
+3,712
+10% +$1.11M 0.51% 55
2015
Q1 		$11M Buy
37,005
+815
+2% +$232K 0.44% 72
2014
Q4 		$9.32M Sell
36,190
-3,071
-8% -$768K 0.39% 84
2014
Q3 		$9.47M Buy
39,261
+907
+2% +$203K 0.4% 85
2014
Q2 		$8.55M Buy
38,354
+33,386
+672% +$6.91M 0.37% 88
2014
Q1 		$1.02M Sell
4,968
-475
-9% -$94.1K 0.05% 270
2013
Q4 		$914K Buy
5,443
+2,478
+84% +$387K 0.04% 274
2013
Q3 		$427K Sell
2,965
-250
-8% -$33.3K 0.02% 344
2013
Q2 		$406K Buy
+3,215
New +$364K 0.02% 338

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Advisors's AGN Position: Q3 2019 in Review

Boston Advisors held its Allergan plc (AGN) position steady in Q3 2019 at 1,380 shares worth $232K. The position accounts for 0.01% of the portfolio, ranked #560.

Boston Advisors first reported a position in AGN in Q2 2013 and has held it in 25 quarters since. The position peaked at $33.9M in Q4 2015. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Boston Advisors held 1,380 shares of Allergan plc worth $232K as of Q3 2019.
  • Boston Advisors left its Allergan plc share count unchanged in Q3 2019.
  • Allergan plc made up 0.01% of Boston Advisors's portfolio in Q3 2019, its #560 holding.
  • Boston Advisors first reported a position in Allergan plc in Q2 2013 and has held it in 25 quarters since.
  • Boston Advisors's Allergan plc position peaked at $33.9M in Q4 2015.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.